Tag: Ianthus
-
![iAnthus (IAN.C) shareholders all but wiped out by Gotham Green Partners in recapitalization deal]()
iAnthus (IAN.C) shareholders all but wiped out by Gotham Green Partners in recapitalization deal
For a large part of its early days, one of the main selling points of US multi state cannabis store operator iAnthus (IAN.C) was that it was seemingly run by adults. Unlike their colleagues at MedMen (MMEN.C), which revealed itself as a self-dealing executive wealth generator from day one, iAnthus painted a picture of experience,…
-
iAnthus (IAN.C) defaults on debenture payments – but is that a weakness or a tactic?
Long time readers know, a year or two back, we wrote a lot about a US multi-state operator (MSO) in the cannabis dispensary space, iAnthus (IAN.C). We liked the company as it accelerated its dispensary acquisition program but stopped coverage in early 2019, with the shareprice in the $5 range, as it began to overpay…
-
What the FDA thinks of Curaleaf (CURA.C), the ‘world’s largest cannabis co.’
On July 22, 2019, the U.S. Food and Drug Administration (FDA) sent a warning letter to Curaleaf Holdings (CURA.C) via overnight delivery. The message was plain: Four of the company’s CBD-infused products are “in violation of sections 505(a) and 301(d) of the Federal Food, Drug, and Cosmetic Act,” and Curaleaf’s CBD products for pets are “unapproved new…
-
Marijuana Update: Ravenquest (RQB.V), CROP (CROP.C), Lifestyle Delivery Systems (LDS.C), iAnthus (IAN.C), and trust
The ability to trust the people you put your money into is of utmost importance. ‘Management’ is oft cited as one of the pillars of a company’s success, but management in this instance could also be defined as ‘trust’. If I asked to borrow money from you in the street, your ability to trust me…
-
iAnthus (IAN.C) retools stock option plan: Pitchforks and torches lowered as shorts bail
Sunlight is the best disinfectant, or so the old saying goes, meaning it’s only when bad things are exposed that bad things are corrected. US multi-state dispensary operator iAnthus (IAN.C), it seems, is soaking up the rays today. Hadley Ford, chief executive officer of iAnthus, stated: “We have cancelled recent option grants to members of…
-
Cannabis Life Sciences (CSE:CLSH.U): The US multi state operator value pick
I love it when the market is busy fighting over inflated market caps, because I’m a Moneyball guy. I like value, and while a lot of money has moved toward Canadian cannabis operators in recent years, the size of the market down south is only now starting to become clear. There’s still some value floating…
-
Too professional: Pure Global (PURE.V) and the companies discounted because they’re actually building businesses
Had a conversation on the phone with Stephen Pynn, VP of Corporate Devs at Pure Global (PURE.V) this week that got me thinking. Pure has had an up and down run since landing on the public markets in July of this year. It ebbs and flows like the tides, never getting really beat up, but also…
-
Gamechanger: iAnthus (IAN.C) and MPX Bioceutical (MPX.C) to merge, go after MedMen (MMEN.C)
A week ago, US dispensary roll-up play MedMen (MMEN.C) closed an $86m financing and a $99.95m loan to help them complete a $682m deal to buy PharmaCann, which has ten dispensaries and three weed grows. It was big news and propelled MMEN stock, which many deem to be overpriced before the deal, substantially higher still.…
-
MedMen (MMEN.C) blows out stock to buy 10 dispensaries, three weed farms in Pharmacann deal
In news that pushed MedMen’s (MMEN.C) share price to new highs, the red shirt crew have announced they’re buying US based Pharmacann LLC for $682 million… or, rather, $682 million of MMEN stock, as of October 9. Mind you, the news drove the company share price up significantly, meaning the actual price now being paid…
